Α-Methylfentanyl: Difference between revisions
CSV import |
CSV import |
||
| Line 27: | Line 27: | ||
{{pharmacology-stub}} | {{pharmacology-stub}} | ||
== Α-Methylfentanyl == | |||
<gallery> | |||
File:Alphamethylfentanyl.svg|Alphamethylfentanyl | |||
File:Α-methylfentanyl 3D BS.png|Α-methylfentanyl 3D BS | |||
File:China White.jpg|China White | |||
File:Fentanyl numbering.svg|Fentanyl numbering | |||
</gallery> | |||
Latest revision as of 00:41, 20 February 2025
Α-Methylfentanyl is a potent opioid analgesic drug that is an analog of fentanyl. It was first identified in the mid-1970s in the United States and has been associated with numerous instances of drug overdose.
Chemistry[edit]
Α-Methylfentanyl, also known as AMF, is a member of the phenylpiperidine class of synthetic opioids. It is structurally related to fentanyl, but differs by the addition of a methyl group on the nitrogen atom. This modification increases the potency of the drug, making it approximately three times stronger than fentanyl.
Pharmacology[edit]
Like other opioids, Α-Methylfentanyl works by binding to the mu-opioid receptor in the brain, which are responsible for mediating the pain-relieving effects of opioids. However, due to its increased potency, it also carries a higher risk of overdose and death.
Effects[edit]
The effects of Α-Methylfentanyl are similar to those of other opioids and include pain relief, sedation, and euphoria. However, it also carries a high risk of respiratory depression, which can be fatal.
Legal Status[edit]
Α-Methylfentanyl is a Schedule I controlled substance in the United States, meaning it has no accepted medical use and a high potential for abuse.
See Also[edit]
References[edit]
<references />
Α-Methylfentanyl[edit]
-
Alphamethylfentanyl
-
Α-methylfentanyl 3D BS
-
China White
-
Fentanyl numbering
